Request a Brochure The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.
Related Articles Company Overview. Revenues generated in fiscal year ; Principal businesses, including discovery, production and marketing of a range of products to improve human and animal health. Strengths, including strong product pipeline, effective investment strategy, and strategic Company overview, including revenues generated in fiscal yearData is included on revenues generated in fiscal year ended Decemberas well as employee strength and location of headquarter.
Address and contact information is given, as well as statistics on revenues, financial year end data and number of employees. New York Ticker code is An overview of the company is given, along with key facts including contact information, number of employees and revenues. A SWOT analysis is provided which includes strengths, weaknesses, Revenues generated in fiscal year ; Principal business offered, including the manufacture Data is included on revenues generated in fiscal year ended Decemberas well as principal business offered, including itsIDEXX Laboratories Inc.
stock price, stock quotes and financial overviews from MarketWatch. Merck & Company, Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American pharmaceutical company and one of the largest pharmaceutical companies in the world.
The global cell free DNA isolation and extraction market is anticipated to grow over $ Million with 14, Thousand units by The market research report offers detailed industry analysis including market size, share, growth, trends and forecast.
SWOT & monstermanfilm.com offers comprehensive and custom solutions on SWOT and PESTLE across industries and organizations as per your needs. We assist organizations, educational institutes and scholars get customized quality research done for minimal costs.
Warwick Brown has led business development and account management teams in Australia and Europe for more than 15 years and worked with some of the world's most prestigious firms, including Merck & Co, Deutsche Bank, McKinsey & Company and Vodafone.
The study is the result of extensive primary and secondary research and some of the key vendors that are mentioned in the report and driving the market are Pfizer, Merck, Teva, Amgen, Abbott, AstraZeneca, Novartis, SUN Pharma, Torrent Pharmaceuticals, GlaxoSmithKline, HanAll BioPharma, JX Pharmaceuticals, Aurobindo Pharma, Abbvie, Cerenis.